FIELD: medicine.
SUBSTANCE: method is implemented by introduction of an effective amount of beta-galactoside-binding lectin or its alkylated form into the uterus of a mammal before the preimplantation period. The invention relates to application of an effective amount of beta-galactoside-binding lectin or its alkylated form to increase the frequency of embryo implantation in a mammal uterus by implementing the method, as well as to a product for increasing the frequency of embryo implantation in a healthy mammal uterus comprising an effective amount of beta-galactoside-binding lectin or its alkylated form.
EFFECT: product application increases the number of embryonic implants in the uterus.
17 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CREATING TRANSGENIC MAMMALS WHICH PRODUCE EXOGENOUS PROTEINS IN MILK, AND TRANSGENIC MAMMALS CREATED USING SAID METHOD | 2004 |
|
RU2390562C2 |
METHOD OF EXOGENIC PROTEIN PRODUCTION IN MILK OF TRANSGENIC MAMMALS AND METHOD OF PURIFICATION OF PROTEINS FROM MILK | 2004 |
|
RU2360002C2 |
UNGULATE EMBRYO CRYOPRESERVATION | 2016 |
|
RU2730597C2 |
METHOD FOR PREDICTION OF EMBRYO QUALITY IN EXTRACORPOREAL FERTILISATION PROGRAMME | 2011 |
|
RU2474823C1 |
CULTURE MEDIUM | 2016 |
|
RU2739619C2 |
USE OF A CYCLIC TRIPEPTIDE TO IMPROVE CELLULAR ENERGY METABOLISM | 2016 |
|
RU2737116C2 |
USE OF SOLUBLE CD146 AS A BIOMARKER FOR SELECTION OF AN IN VITRO FERTILIZED EMBRYO FOR IMPLANTATION TO A MAMMAL | 2016 |
|
RU2735542C2 |
HYBRID DAIRY CATTLE AND SYSTEMS FOR MAXIMIZING THE BENEFIT OF USING THE HYBRID | 2015 |
|
RU2721252C2 |
METHOD FOR PREDICTING ECF AND ET PROGRAM RESULTS | 2004 |
|
RU2273031C1 |
TRANSGENESIS DUE TO INTRACYTOPLASMATIC SPERMATIC INJECTION IN MAMMALIANS | 1999 |
|
RU2267270C2 |
Authors
Dates
2017-09-25—Published
2011-12-09—Filed